Talphera TLPH
NASDAQ TLPH
$1.19 +0.00 (+0.00%)
At close: Aug 21, 2026 · 4:00 PM EDT

Talphera (TLPH) Depreciation & Amortization (CF) (2010 - 2023)

Talphera (TLPH) posted quarterly Depreciation & Amortization (CF) of $49000.0 for Q2 2023, down 89.37% year-over-year from $461000.0 in Q2 2022, and down 81.3% quarter-over-quarter from $262000.0 in Q1 2023.

Talphera (TLPH) Depreciation & Amortization (CF) (2010 - 2023) Analysis & Trends

Talphera's Depreciation & Amortization (CF) history runs 14 years deep, the most recent figure standing at $49000.0 for Q2 2023.

  • In Q2 2023, Depreciation & Amortization (CF) fell 89.37% year-over-year to $49000.0; the TTM figure through Mar 2024 stood at $49000.0 (down 96.71% YoY), while the FY2023 annual figure was $311000.0, down 81.12% from the prior year.
  • Depreciation & Amortization (CF) for Q2 2023 stood at $49000.0, down from $262000.0 in the prior quarter.
  • The five-year high for Depreciation & Amortization (CF) was $579000.0 in Q2 2021, with the low at $49000.0 in Q2 2023.
  • The 5-year median for Depreciation & Amortization (CF) is $437000.0 (2021), against an average of $414000.0.
  • The sharpest annual moves came in 2019 and 2023: Depreciation & Amortization (CF) jumped 267.86% in 2019, then slumped 89.37% in 2023.
  • Talphera's Depreciation & Amortization (CF) stood at $515000.0 in 2019, then dropped by 25.83% to $382000.0 in 2020, then increased by 20.68% to $461000.0 in 2021, then dropped by 25.81% to $342000.0 in 2022, then plunged by 85.67% to $49000.0 in 2023.
  • Business Quant data shows TLPH's Depreciation & Amortization (CF) at $49000.0 in Q2 2023, $262000.0 in Q1 2023, and $342000.0 in Q4 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Haleon 44.51 Bn 43.55 Bn - -
2 Teva Pharmaceutical Industries 43.52 Bn 39.86 Bn 2.15 Bn 241.00 Mn
3 Zoetis 32.43 Bn 30.75 Bn 1.05 Bn 119.00 Mn
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn 1.02 Bn
5 United Therapeutics 21.87 Bn 19.21 Bn 683.80 Mn 24.20 Mn
6 Viatris 18.98 Bn 18.09 Bn 1.46 Bn 672.30 Mn
7 Neurocrine Biosciences 15.43 Bn 15.04 Bn 935.80 Mn -
8 Elanco Animal Health 12.02 Bn 11.49 Bn 798.00 Mn 171.00 Mn
9 Dr Reddys Laboratories 10.14 Bn 9.98 Bn - -
10 Talphera 90.25 Mn 90.25 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2023 49,000.00
Jun 30, 2023 49,000.00
Mar 31, 2023 262,000.00
Mar 31, 2023 262,000.00
Dec 31, 2022 342,000.00
Dec 31, 2022 342,000.00
Sep 30, 2022 424,000.00
Sep 30, 2022 424,000.00
Jun 30, 2022 461,000.00
Jun 30, 2022 461,000.00
Mar 31, 2022 420,000.00
Mar 31, 2022 420,000.00
Dec 31, 2021 461,000.00
Dec 31, 2021 461,000.00
Sep 30, 2021 483,000.00
Sep 30, 2021 483,000.00
Jun 30, 2021 579,000.00
Jun 30, 2021 579,000.00
Mar 31, 2021 450,000.00
Mar 31, 2021 450,000.00